(1 - 12 from 24
)
More change at the FDA as John Jenkins steps down - MedCity News
medcitynews.com
Director of the FDA's Office of New Drugs, John Jenkins, will reportedly step down in early January. His retirement comes at a challenging time, as the agency...
sorted by relevance / date